SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alfacell (ACEL)
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
1533 6 0 ACEL
Emcee:  Gil Kempenich Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
258 Mark Please reread my post. You are preaching to the choir. 1. Alfacell has GCL-2/4/1997
257 George - 1. <i>Alfacell has no money</i> - perhaps those brokers Mark Chavez-2/4/1997
256 Gant, thanks for the information. What I am worried about is the outlook of prGCL-2/4/1997
255 Thanks, Gant, for the in-depth information. Very informative and positive. HoGil Kempenich-2/4/1997
254 In response to your questions concerning Onconase vs Gemzar; we are dealing witgant-2/3/1997
253 It was sure refreshing to see your message. Maybe this is John Gault from one oleighton stallones-2/2/1997
252 Gil -- Thanks for the URLs. I was able to download the article from the pathfiJohn Jenco-1/31/1997
251 Hi, Gant, and welcome to SI and the Alfacell thread. We welcome and value new Gil Kempenich-1/31/1997
250 To Gil and all Alfacell owners: ACEL is not a stock you need to worry over and gant-1/31/1997
249 There is fortune online version. Not sure what article you are looking for, buGil Kempenich-1/31/1997
248 John, It's the January 13, 1997 issue of Fortune. Check your library or caJon McHugh-1/31/1997
247 John, I have the article at home, I think... If I can find it tonight, I will Jon McHugh-1/30/1997
246 Jon -- You mentioned a Fortune magazine article some time back. I've not bJohn Jenco-1/29/1997
245 There is likely a success story in the making here, based on what we ACEL experGil Kempenich-1/29/1997
244 They have been accurate in the past , a little off on timing but the informatioGreg Kevorkian-1/28/1997
243 I believe the report info to be accurate and I think the road shows will be verleighton stallones-1/28/1997
242 I also heard that the report was at the printers. The road show will commence Greg Kevorkian-1/28/1997
241 Gil I have a position in Agouron (AGPH) as well as ACEL and follow AGPH closelTom DuBois-1/28/1997
240 Side issue - I read about Agouron and Viracept - company is still working on geGil Kempenich-1/28/1997
239 I learned that the Faulkner report went to the printer yesterday and should be B Michael Pisani-1/28/1997
238 Leighton, How can a small buy and or sell, 300 to 400 shares, cause this stockGCL-1/27/1997
237 Yes I know, thats the note payment sale I was referring to in #233.leighton stallones-1/25/1997
236 Check edgar. If I read it right Shogen disposed of 10,000 shares at 7.88. No bfmrick-1/25/1997
235 I am buying what I can here.I believe it is extremely undervalued. Chart shows leighton stallones-1/24/1997
234 Leighton, I tend to agree with you. I have observed this historically with ACGil Kempenich-1/24/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News